Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment|
- Subject compliance with Foresee HomeTM device [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Assessment of the Telemedicine infrastructure [ Time Frame: 6 months ] [ Designated as safety issue: No ]
|Study Start Date:||October 2009|
|Study Completion Date:||September 2010|
|Primary Completion Date:||March 2010 (Final data collection date for primary outcome measure)|
subjects diagnosed as intermediate AMD in at least one eye
Device: FORESEE HOME
This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.